If preclinical testing is successful, the vaccine candidate moves to Phase 1 clinical trials. This phase involves a small group of healthy volunteers and focuses on further assessing the vaccine's safety and immune response. Regulatory agencies review the preclinical data before granting approval to proceed to human trials.
